Back
Precision BioSciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
28
DTIL
Precision BioSciences
Last Price:
8.50
Seasonality Move:
29.92%
Sell
28
NBY
NovaBay Pharmaceuticals
Last Price:
0.61
Seasonality Move:
-16.74%
Sell
28
Precision BioSciences (DTIL)
is a Sell
Is Precision BioSciences a Buy, Sell or Hold?
- The current Precision BioSciences [DTIL] share price is $8.78. The Score for DTIL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- DTIL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DTIL Stock Price Chart
What is Precision BioSciences's stock price today?
-
The Precision BioSciences share price today is $8.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
DTIL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 37.6 | Sell |
Chaikin Money Flow: | -14764 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.86 - 9.5) | Sell |
Bollinger Bands (100): | (8.8 - 10.96) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 42.74 | Sell |
Chaikin Money Flow: | 36308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.72) | Sell |
Bollinger Bands (100): | (0.35 - 2.23) | Sell |
DTIL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.89 | Sell |
20-day SMA: | 9.06 | Sell |
50-day SMA: | 9.47 | Sell |
200-day SMA: | 11.03 | Sell |
8-day EMA: | 8.91 | Sell |
20-day EMA: | 9.11 | Sell |
50-day EMA: | 9.43 | Sell |
200-day EMA: | 11.61 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.61 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.57 | Buy |
200-day SMA: | 2.9 | Sell |
8-day EMA: | 0.62 | Sell |
20-day EMA: | 0.63 | Sell |
50-day EMA: | 0.78 | Sell |
200-day EMA: | 6.83 | Sell |
Precision BioSciences Earnings Growth & DTIL Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.40 per share, and a decrease next year of $3.05 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Precision BioSciences Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |